6678.T JPX
Techno Medica Co., Ltd.
1W: -2.2%
1M: -2.2%
3M: +1.6%
YTD: -19.4%
1Y: +2.7%
3Y: +0.8%
5Y: +44.4%
¥2,000.00 ($12.67)
-24.00 (-1.19%)
Weekly Expected Move ±1.9%
¥1922
¥1961
¥2000
¥2039
¥2078
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$17.9B
+2.9% ▲
5Y CAGR: +1.6%
Total Liabilities
$3.5B
-1.8% ▼
5Y CAGR: +8.0%
Shareholders Equity
$14.4B
+4.1% ▲
5Y CAGR: +0.3%
Cash & Investments
$9.1B
+5.5% ▲
5Y CAGR: -1.5%
Total Debt
$0
+0.0% ▲
Net Debt
-$9.1B
-5.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10.1B | $11.5B | $11.8B | $8.6B | $9.1B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $10.1B | $11.5B | $11.8B | $8.6B | $9.1B |
| Net Receivables | $3.6B | $3.7B | $3.6B | $3.5B | $4.0B |
| Inventory | $1.6B | $1.2B | $1.9B | $2.2B | $2.6B |
| Other Current Assets | $36M | $31M | $89M | $764M | $6M |
| Total Current Assets | $15.5B | $16.5B | $17.3B | $15.1B | $15.7B |
| Property, Plant & Equip. | $1.6B | $1.5B | $1.5B | $1.4B | $1.4B |
| Goodwill & Intangibles | $24M | $33M | $23M | $71M | $60M |
| Long-Term Investments | $8M | $8M | $8M | $8M | $8M |
| Other Non-Current Assets | $163M | $139M | $203M | $402M | $323M |
| Total Non-Current Assets | $2.1B | $2.0B | $2.1B | $2.4B | $2.3B |
| Total Assets | $17.6B | $18.5B | $19.4B | $17.4B | $17.9B |
| — Liabilities — | |||||
| Accounts Payable | $1.1B | $1.3B | $1.5B | $1.4B | $1.6B |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $134M | $115M | $99M | $96M | $108M |
| Other Current Liabilities | $552M | $684M | $776M | $1.3B | $1.3B |
| Total Current Liabilities | $2.4B | $2.6B | $2.8B | $3.4B | $3.3B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $210M | $228M | $246M | $256M | $274M |
| Total Non-Current Liabilities | $210M | $228M | $246M | $256M | $274M |
| Total Liabilities | $2.6B | $2.9B | $3.1B | $3.6B | $3.5B |
| — Equity — | |||||
| Common Stock | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| Retained Earnings | $4.6B | $5.5B | $6.1B | $6.9B | $7.4B |
| Accumulated OCI | $8.8B | $8.8B | $8.8B | $1M | $18M |
| Total Stockholders Equity | $15.0B | $15.7B | $16.4B | $13.8B | $14.4B |
| Total Liabilities & Equity | $17.6B | $18.5B | $19.4B | $17.4B | $17.9B |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$10.1B | -$11.5B | -$11.8B | -$8.6B | -$9.1B |
| Total Investments | $8M | $8M | $8M | $8M | $8M |